IFM Investors Pty Ltd Boosts Stake in The Clorox Company $CLX

IFM Investors Pty Ltd raised its position in shares of The Clorox Company (NYSE:CLX) by 4.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 24,131 shares of the company’s stock after acquiring an additional 1,017 shares during the period. IFM Investors Pty Ltd’s holdings in Clorox were worth $2,897,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in CLX. Vident Advisory LLC purchased a new stake in Clorox during the fourth quarter valued at about $456,000. Vise Technologies Inc. purchased a new stake in Clorox during the fourth quarter valued at about $250,000. Public Employees Retirement System of Ohio grew its position in Clorox by 0.5% during the fourth quarter. Public Employees Retirement System of Ohio now owns 60,035 shares of the company’s stock valued at $9,750,000 after acquiring an additional 269 shares during the period. Mackenzie Financial Corp lifted its stake in shares of Clorox by 30.5% during the fourth quarter. Mackenzie Financial Corp now owns 13,464 shares of the company’s stock worth $2,187,000 after purchasing an additional 3,148 shares in the last quarter. Finally, American Trust purchased a new stake in shares of Clorox in the fourth quarter worth about $293,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 1.3%

Shares of Clorox stock opened at $120.06 on Tuesday. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The Clorox Company has a 1 year low of $116.53 and a 1 year high of $171.37. The stock has a 50-day moving average price of $123.89 and a 200 day moving average price of $130.93. The company has a market cap of $14.68 billion, a P/E ratio of 18.41, a P/E/G ratio of 0.98 and a beta of 0.52.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. During the same period in the prior year, the firm posted $1.82 EPS. The business’s revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be given a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 4.1%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox’s dividend payout ratio is presently 76.07%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on CLX shares. Citigroup reaffirmed a “neutral” rating and issued a $135.00 target price (down previously from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. Morgan Stanley cut their target price on Clorox from $150.00 to $137.00 and set an “equal weight” rating on the stock in a research report on Friday, August 1st. Barclays lowered their price target on Clorox from $129.00 to $119.00 and set an “underweight” rating for the company in a report on Tuesday, July 15th. JPMorgan Chase & Co. boosted their price target on Clorox from $133.00 to $135.00 and gave the company a “neutral” rating in a report on Monday, September 8th. Finally, Wells Fargo & Company lowered their price objective on Clorox from $138.00 to $130.00 and set an “equal weight” rating for the company in a research note on Friday, September 5th. One research analyst has rated the stock with a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Reduce” and an average price target of $142.18.

Insider Activity at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.57% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.